Correlation Between Wuhan Hvsen and Shenzhen Centralcon

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Wuhan Hvsen and Shenzhen Centralcon at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Wuhan Hvsen and Shenzhen Centralcon into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Wuhan Hvsen Biotechnology and Shenzhen Centralcon Investment, you can compare the effects of market volatilities on Wuhan Hvsen and Shenzhen Centralcon and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Wuhan Hvsen with a short position of Shenzhen Centralcon. Check out your portfolio center. Please also check ongoing floating volatility patterns of Wuhan Hvsen and Shenzhen Centralcon.

Diversification Opportunities for Wuhan Hvsen and Shenzhen Centralcon

0.92
  Correlation Coefficient

Almost no diversification

The 3 months correlation between Wuhan and Shenzhen is 0.92. Overlapping area represents the amount of risk that can be diversified away by holding Wuhan Hvsen Biotechnology and Shenzhen Centralcon Investment in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Shenzhen Centralcon and Wuhan Hvsen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Wuhan Hvsen Biotechnology are associated (or correlated) with Shenzhen Centralcon. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Shenzhen Centralcon has no effect on the direction of Wuhan Hvsen i.e., Wuhan Hvsen and Shenzhen Centralcon go up and down completely randomly.

Pair Corralation between Wuhan Hvsen and Shenzhen Centralcon

Assuming the 90 days trading horizon Wuhan Hvsen Biotechnology is expected to under-perform the Shenzhen Centralcon. But the stock apears to be less risky and, when comparing its historical volatility, Wuhan Hvsen Biotechnology is 1.12 times less risky than Shenzhen Centralcon. The stock trades about -0.03 of its potential returns per unit of risk. The Shenzhen Centralcon Investment is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest  884.00  in Shenzhen Centralcon Investment on September 1, 2024 and sell it today you would lose (344.00) from holding Shenzhen Centralcon Investment or give up 38.91% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy100.0%
ValuesDaily Returns

Wuhan Hvsen Biotechnology  vs.  Shenzhen Centralcon Investment

 Performance 
       Timeline  
Wuhan Hvsen Biotechnology 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Wuhan Hvsen Biotechnology are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Wuhan Hvsen sustained solid returns over the last few months and may actually be approaching a breakup point.
Shenzhen Centralcon 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Shenzhen Centralcon Investment are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Shenzhen Centralcon sustained solid returns over the last few months and may actually be approaching a breakup point.

Wuhan Hvsen and Shenzhen Centralcon Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Wuhan Hvsen and Shenzhen Centralcon

The main advantage of trading using opposite Wuhan Hvsen and Shenzhen Centralcon positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Wuhan Hvsen position performs unexpectedly, Shenzhen Centralcon can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shenzhen Centralcon will offset losses from the drop in Shenzhen Centralcon's long position.
The idea behind Wuhan Hvsen Biotechnology and Shenzhen Centralcon Investment pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Complementary Tools

Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data